Lesch M E, Ferin M A, Wright C D, Schrier D J
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
Agents Actions. 1991 Sep;34(1-2):25-7. doi: 10.1007/BF01993227.
L-PIA, a standard A1-selective adenosine agonist, was evaluated orally in carrageenan (CRG)- and reverse passive arthus-pleurisy. White blood cell (WBC) and exudate accumulation were assessed four hours after induction of the inflammatory response. L-PIA inhibited WBC accumulation in both models with ID50's of 4.37 and 4.42 mg/kg, respectively. In contrast, exudate was inhibited by L-PIA only in the CRG pleurisy model (ID50 = 1.01 mg/kg). In mechanistic studies, L-PIA reversed the drop in circulating neutrophil count which occurred within 15 minutes after CRG injection, suggesting that L-PIA may inhibit adhesion of the cells to the endothelium. The effects of L-PIA on several parameters of rat neutrophil function were determined. Enzyme release, O2-, TXB2, and LTB4 production were monitored in response to FMLP and opsonized zymosan (SOZ) stimulation. At high concentrations, L-PIA had a mild inhibitory effect on O2- release in response to FMLP and had a moderate effect on arachidonic acid metabolite production in response to both stimuli. The other response were unaffected. These results suggest that L-PIA may prevent diapedisis or neutrophil adhesion to the endothelium, but has a minimal effect on enzyme release, O2-, LTB4 and TXB2 production.
L-PIA是一种标准的A1选择性腺苷激动剂,通过口服方式在角叉菜胶(CRG)诱导的胸膜炎和被动反向阿瑟斯胸膜炎模型中进行评估。在诱导炎症反应4小时后,评估白细胞(WBC)和渗出液的积聚情况。L-PIA在两种模型中均抑制WBC积聚,其半数抑制剂量(ID50)分别为4.37和4.42mg/kg。相比之下,L-PIA仅在CRG胸膜炎模型中抑制渗出液(ID50 = 1.01mg/kg)。在机制研究中,L-PIA逆转了CRG注射后15分钟内循环中性粒细胞计数的下降,这表明L-PIA可能抑制细胞与内皮的黏附。测定了L-PIA对大鼠中性粒细胞功能的几个参数的影响。监测了在佛波酯(FMLP)和调理酵母聚糖(SOZ)刺激下的酶释放、超氧阴离子(O2-)、血栓素B2(TXB2)和白三烯B4(LTB4)的产生。在高浓度下,L-PIA对FMLP刺激引起的O2-释放有轻度抑制作用,对两种刺激引起的花生四烯酸代谢产物产生有中度影响。其他反应未受影响。这些结果表明,L-PIA可能阻止中性粒细胞渗出或与内皮的黏附,但对酶释放、O2-、LTB4和TXB2的产生影响极小。